Evaluating Biochemically Recurrent Prostate Cancer: Histologic Validation of <sup>18</sup>F-DCFPyL PET/CT with Comparison to Multiparametric MRI

Evaluating Biochemically Recurrent Prostate Cancer: Histologic Validation of <sup>18</sup>F-DCFPyL PET/CT with Comparison to Multiparametric MRI

Background Prostate cancer recurrence is found in up to 40% of men with prior definitive (total prostatectomy or whole-prostate radiation) treatment. Prostate-specific membrane antigen PET agents such as 2-(3-{1-carboxy-5-[(6-[18F]fluoro-pyridine 3-carbonyl)-amino]-pentyl}-ureido)-pentanedioic acid...

全面介紹

Saved in:
書目詳細資料
Main Authors: Liza Lindenberg, Esther Mena, Barış Türkbey, Joanna H. Shih, Sarah E. Reese, Stephanie A. Harmon, Ilhan Lim, Frank I. Lin, Anita Ton, Yolanda McKinney, Philip Eclarinal, Deborah E. Citrin, William L. Dahut, Ravi A. Madan, Bradford J. Wood, Venkatesh Krishnasamy, Richard Chang, Elliot Levy, Peter A. Pinto, Janet F. Eary, Peter L. Choyke
格式: Artigo
語言:英语
出版: 2020
在線閱讀:https://doi.org/10.1148/radiol.2020192018
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

因特網

https://doi.org/10.1148/radiol.2020192018

相似書籍